124 related articles for article (PubMed ID: 21266446)
1. Eotaxin-3 in Churg-Strauss syndrome: a clinical and immunogenetic study.
Zwerina J; Bach C; Martorana D; Jatzwauk M; Hegasy G; Moosig F; Bremer J; Wieczorek S; Moschen A; Tilg H; Neumann T; Spriewald BM; Schett G; Vaglio A
Rheumatology (Oxford); 2011 Oct; 50(10):1823-7. PubMed ID: 21266446
[TBL] [Abstract][Full Text] [Related]
2. Eotaxin-3 is involved in Churg-Strauss syndrome--a serum marker closely correlating with disease activity.
Polzer K; Karonitsch T; Neumann T; Eger G; Haberler C; Soleiman A; Hellmich B; Csernok E; Distler J; Manger B; Redlich K; Schett G; Zwerina J
Rheumatology (Oxford); 2008 Jun; 47(6):804-8. PubMed ID: 18397958
[TBL] [Abstract][Full Text] [Related]
3. Functionally relevant variations of the interleukin-10 gene associated with antineutrophil cytoplasmic antibody-negative Churg-Strauss syndrome, but not with Wegener's granulomatosis.
Wieczorek S; Hellmich B; Arning L; Moosig F; Lamprecht P; Gross WL; Epplen JT
Arthritis Rheum; 2008 Jun; 58(6):1839-48. PubMed ID: 18512809
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis of Churg-Strauss syndrome: eotaxin-3 makes it easier.
Buzio C; Oliva E
Rheumatology (Oxford); 2011 Oct; 50(10):1737-8. PubMed ID: 21292740
[No Abstract] [Full Text] [Related]
5. Serum eosinophil cationic protein: a marker of disease activity in Churg-Strauss syndrome.
Guilpain P; Auclair JF; Tamby MC; Servettaz A; Mahr A; Weill B; Guillevin L; Mouthon L
Ann N Y Acad Sci; 2007 Jun; 1107():392-9. PubMed ID: 17804567
[TBL] [Abstract][Full Text] [Related]
6. Proinflammatory cytokines and autoimmunity in Churg-Strauss syndrome.
Hellmich B; Csernok E; Gross WL
Ann N Y Acad Sci; 2005 Jun; 1051():121-31. PubMed ID: 16126951
[TBL] [Abstract][Full Text] [Related]
7. Potential of blood eosinophils, eosinophil-derived neurotoxin, and eotaxin-3 as biomarkers of eosinophilic esophagitis.
Konikoff MR; Blanchard C; Kirby C; Buckmeier BK; Cohen MB; Heubi JE; Putnam PE; Rothenberg ME
Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1328-36. PubMed ID: 17059896
[TBL] [Abstract][Full Text] [Related]
8. HLA-DRB4 as a genetic risk factor for Churg-Strauss syndrome.
Vaglio A; Martorana D; Maggiore U; Grasselli C; Zanetti A; Pesci A; Garini G; Manganelli P; Bottero P; Tumiati B; Sinico RA; Savi M; Buzio C; Neri TM;
Arthritis Rheum; 2007 Sep; 56(9):3159-66. PubMed ID: 17763415
[TBL] [Abstract][Full Text] [Related]
9. Intrinsic pathway of apoptosis in peripheral blood eosinophils of Churg-Strauss syndrome.
Jakiela B; Szczeklik W; Sokolowska B; Mastalerz L; Sanak M; Plutecka H; Szczeklik A
Rheumatology (Oxford); 2009 Oct; 48(10):1202-7. PubMed ID: 19643727
[TBL] [Abstract][Full Text] [Related]
10. [Churg-Strauss syndrome].
Garini G; Corradi D; Vaglio A; Buzio C
Recenti Prog Med; 2003 Dec; 94(12):573-81. PubMed ID: 14974155
[TBL] [Abstract][Full Text] [Related]
11. [Hypereosinophilic syndrome associated with antineutrophil cytoplasmic antibody].
Yoshimura N; Nishimori F; Yamazaki K; Jin Y; Beppu H; Nodera H; Matsubara O
Nihon Kokyuki Gakkai Zasshi; 1999 Jul; 37(7):554-9. PubMed ID: 10481462
[TBL] [Abstract][Full Text] [Related]
12. Familial vasculitides: Churg-Strauss syndrome and Wegener's granulomatosis in 2 first-degree relatives.
Manganelli P; Giacosa R; Fietta P; Zanetti A; Neri TM
J Rheumatol; 2003 Mar; 30(3):618-21. PubMed ID: 12610825
[TBL] [Abstract][Full Text] [Related]
13. Churg-Strauss syndrome.
Keogh KA; Specks U
Semin Respir Crit Care Med; 2006 Apr; 27(2):148-57. PubMed ID: 16612766
[TBL] [Abstract][Full Text] [Related]
14. Churg-Strauss syndrome: serum markers of lymphocyte activation and endothelial damage.
Schmitt WH; Csernok E; Kobayashi S; Klinkenborg A; Reinhold-Keller E; Gross WL
Arthritis Rheum; 1998 Mar; 41(3):445-52. PubMed ID: 9506572
[TBL] [Abstract][Full Text] [Related]
15. Initial cutaneous manifestations consistent with mononeuropathy multiplex in Churg-Strauss syndrome.
Kawakami T; Soma Y; Kawasaki K; Kawase A; Mizoguchi M
Arch Dermatol; 2005 Jul; 141(7):873-8. PubMed ID: 16027304
[TBL] [Abstract][Full Text] [Related]
16. Antineutrophil cytoplasm antibodies in systemic polyarteritis nodosa with and without hepatitis B virus infection and Churg-Strauss syndrome--62 patients.
Guillevin L; Visser H; Noel LH; Pourrat J; Vernier I; Gayraud M; Oksman F; Lesavre P
J Rheumatol; 1993 Aug; 20(8):1345-9. PubMed ID: 7901412
[TBL] [Abstract][Full Text] [Related]
17. Elevated serum eotaxin levels in patients with inflammatory bowel disease.
Mir A; Minguez M; Tatay J; Pascual I; Peña A; Sanchiz V; Almela P; Mora F; Benages A
Am J Gastroenterol; 2002 Jun; 97(6):1452-7. PubMed ID: 12094864
[TBL] [Abstract][Full Text] [Related]
18. 12-hydroxy-eicosatetraenoic acid (12-HETE): a biomarker of Churg-Strauss syndrome.
Szczeklik W; Sanak M; Mastalerz L; Sokołowska BM; Gielicz A; Soja J; Kumik J; Musiał J; Szczeklik A
Clin Exp Allergy; 2012 Apr; 42(4):513-22. PubMed ID: 22417211
[TBL] [Abstract][Full Text] [Related]
19. Improved differentiation between Churg-Strauss syndrome and Wegener's granulomatosis by an artificial neural network.
Schmitt WH; Linder R; Reinhold-Keller E; Gross WL
Arthritis Rheum; 2001 Aug; 44(8):1887-96. PubMed ID: 11508442
[TBL] [Abstract][Full Text] [Related]
20. A hexanucleotide repeat upstream of eotaxin gene promoter is associated with asthma, serum total IgE and plasma eotaxin levels.
Batra J; Rajpoot R; Ahluwalia J; Devarapu SK; Sharma SK; Dinda AK; Ghosh B
J Med Genet; 2007 Jun; 44(6):397-403. PubMed ID: 17220216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
